Market revenue in 2023 | USD 1.9 million |
Market revenue in 2030 | USD 3.0 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Malignant tumors |
Fastest growing segment | Functional Disorders |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases |
Key market players worldwide | Elekta AB ADR, Varian, Akesis Pharmaceuticals, Huiheng Industry |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gamma knife market will help companies and investors design strategic landscapes.
Malignant tumors was the largest segment with a revenue share of 47.37% in 2023. Horizon Databook has segmented the UAE gamma knife market based on malignant tumors, benign tumors, vascular disorders, functional disorders, ocular diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Improved healthcare expenditure of the UAE is expected to boost its market. In 2018, the healthcare expenditure through GDP reached USD 1.32 billion in 2020 from USD 1.04 billion in2016. This ensures the inclination of the country toward adopting highly advanced technologies, such as SRS, which is expected to positively influence market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE gamma knife market , including forecasts for subscribers. This country databook contains high-level insights into UAE gamma knife market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account